An investigational drug did not significantly improve outcomes versus quetiapine extended release (Seroquel XR) as an adjunctive treatment in adults with major depressive disorder (MDD) and insomnia ...
Current Primary Outcome Measures •Percentage of Participants with Response (>=50 Percent improvement in MADRS total score from baseline) at Week 26 [ Time Frame: Week 26 ] -- Responders are defined as ...
Adding cognitive behavioral therapy to quetiapine in mood disorders is linked to reduced suicide risk and depressive symptoms ...
May 24, 2007 (San Diego) — A recent study found that among patients in a psychiatric hospital, the atypical antipsychotic quetiapine (Seroquel, AstraZeneca), which is approved for schizophrenia and ...
Augmentation was more effective with quetiapine than lithium for treatment-resistant depression in a pragmatic trial. Quetiapine also improved quality-adjusted life years more than lithium. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results